Two Data Breaches Didn’t Sink Novo Nordisk’s Stock. Why Not?

Two separate groups, including one calling itself FulcrumSec and another named TheUSERS007, claim to have breached Novo Nordisk and stolen sensitive internal documents and clinical trial intellectual property, each demanding large ransoms ($25M and $50M) and leaking data after nonpayment; the report notes limited public disclosure from the company and little immediate impact on its stock price.